Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2Pas …

S Fereshteh, S Ajdary, A Sepehr, N Bolourchi… - Microbial …, 2023 - Elsevier
Backgrounds The prevalence of infections associated with multi-drug resistant (MDR)
Acinetobacter baumannii is increasing worldwide. Therefore, the introduction of effective …
被引用次数：7 相关文章

Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2Pas …

S Fereshteh, S Ajdary, A Sepehr… - Microbial …, 2023 - pubmed.ncbi.nlm.nih.gov
Backgrounds The prevalence of infections associated with multi-drug resistant (MDR)
Acinetobacter baumannii is increasing worldwide. Therefore, the introduction of effective …

[引用][C] Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii …

S Fereshteh, S Ajdary, A Sepehr… - Microbial …, 2023 - espace.library.uq.edu.au
Backgrounds: The prevalence of infections associated with multi-drug resistant (MDR)
Acinetobacter baumannii is increasing worldwide. Therefore, the introduction of effective …

Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2Pas …

S Fereshteh, S Ajdary, A Sepehr, N Bolourchi… - Microbial …, 2022 - europepmc.org
Methods AbOmpA and DcaP-like protein were selected as promising and putative
immunogenic candidates based on previous in silico studies. Three formulations including …